Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Alibaba
BABA
|
$439M |
| 2 |
Spotify
SPOT
|
$387M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$283M |
| 4 |
Microsoft
MSFT
|
$238M |
| 5 |
Wayfair
W
|
$198M |
Top Sells
| 1 |
Baidu
BIDU
|
$554M |
| 2 |
MarketAxess Holdings
MKTX
|
$331M |
| 3 |
Visa
V
|
$288M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$263M |
| 5 |
BLUE
bluebird bio
BLUE
|
$242M |
Sector Composition
| 1 | Consumer Discretionary | 34.47% |
| 2 | Healthcare | 16.47% |
| 3 | Communication Services | 15.64% |
| 4 | Technology | 12.03% |
| 5 | Financials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Zai Lab
ZLAB
$3.68B
| $126M | 0.12% | 3,039,700 -96,400 | -3% | -$4.01M |
|
102
Stitch Fix
SFIX
$690M
| $121M | 0.12% | 4,724,391 +241,532 | +5% | +$6.2M |
|
103
DNOW Inc
DNOW
$1.68B
| $118M | 0.11% | 10,519,170 -5,779,793 | -35% | -$65M |
|
104
HEICO Class A
HEI.A
$34.1B
| $111M | 0.11% | 1,239,184 +24,100 | +2% | +$2.16M |
|
|
ATVI
105
DELISTED
Activision Blizzard Inc.
ATVI
| $110M | 0.11% | 1,849,922 -59,441 | -3% | -$3.53M |
|
|
PLAN
106
DELISTED
Anaplan, Inc.
PLAN
| $98.1M | 0.09% | 1,871,644 | – | – |
|
|
NEWR
107
DELISTED
New Relic, Inc.
NEWR
| $86.1M | 0.08% | 1,309,695 +70,847 | +6% | +$4.66M |
|
108
Sea Limited
SE
$110B
| $82.2M | 0.08% | 2,043,646 +94,232 | +5% | +$3.79M |
|
109
Fastenal
FAST
$57B
| $79.3M | 0.08% | 2,145,502 -5,375 | -0.2% | -$199K |
|
110
MakeMyTrip
MMYT
$9.4B
| $75.7M | 0.07% | 3,306,787 +100,065 | +3% | +$2.29M |
|
111
Petrobras Class A
PBR.A
$73.9B
| $70.8M | 0.07% | 4,743,773 +141,334 | +3% | +$2.11M |
|
112
STAAR Surgical
STAA
$1.36B
| $68.3M | 0.07% | 1,942,929 +34,641 | +2% | +$1.22M |
|
113
Moderna
MRNA
$9.37B
| $66.8M | 0.06% | 3,416,113 +201,316 | +6% | +$3.94M |
|
114
Exact Sciences
EXAS
$8.98B
| $66.6M | 0.06% | 720,494 +103,524 | +17% | +$9.57M |
|
115
Coca-Cola
KO
$297B
| $64.5M | 0.06% | 1,165,472 +11,184 | +1% | +$619K |
|
116
Eventbrite
EB
$256M
| $62.9M | 0.06% | 3,117,611 +169,344 | +6% | +$3.42M |
|
117
Pacira BioSciences
PCRX
$1.2B
| $62.9M | 0.06% | 1,387,445 +235,735 | +20% | +$10.7M |
|
|
JMIA
118
Jumia Technologies
JMIA
$1.05B
| $62.2M | 0.06% | 9,242,106 +235,008 | +3% | +$1.58M |
|
|
BLUE
119
DELISTED
bluebird bio
BLUE
| $61M | 0.06% | 695,608 -2,760,208 | -80% | -$242M |
|
120
Procter & Gamble
PG
$368B
| $60.7M | 0.06% | 485,952 +1,742 | +0.4% | +$218K |
|
121
Codexis
CDXS
$246M
| $60.6M | 0.06% | 3,788,034 +516,934 | +16% | +$8.27M |
|
|
SPLK
122
DELISTED
Splunk Inc
SPLK
| $52.9M | 0.05% | 353,377 +14,088 | +4% | +$2.11M |
|
123
Trupanion
TRUP
$1.99B
| $51.6M | 0.05% | 1,377,130 +32,268 | +2% | +$1.21M |
|
124
AeroVironment
AVAV
$12.1B
| $50.5M | 0.05% | 817,695 +22,049 | +3% | +$1.36M |
|
125
PepsiCo
PEP
$204B
| $50.5M | 0.05% | 369,340 +6,203 | +2% | +$848K |
|